Core Viewpoint - The company announced the postponement of the completion dates for several fundraising investment projects due to various external factors, ensuring that the use of raised funds remains compliant and effective [1] Group 1: Project Delays - The completion date for the "Integrated Natural Plant Extraction Project (Phase I)" has been postponed to June 30, 2027 [1] - The "Nutritional Medicinal Comprehensive Extraction Project (Phase I)" is now expected to be completed by April 30, 2027 [1] - The "Zambia Land Development and Supporting Infrastructure Construction Project" will now reach its intended operational status by December 31, 2026 [1] Group 2: Reasons for Delay - The delays are attributed to changes in the global economic environment, slow market expansion, and ongoing optimization of production processes [1] Group 3: Impact on Operations - The company stated that these delays will not have a significant adverse impact on its normal operations [1]

Group 1 - The company held its third board meeting and supervisory board meeting on June 17, 2025, where it approved the use of its own foreign exchange funds to pay for the investment project and to replace it with raised funds [2][7][9] - The company successfully raised a total of RMB 182,032.60 million by issuing 14,470,000 shares at a price of RMB 125.80 per share, with a net amount of RMB 165,101.28 million after deducting issuance costs [2][43][44] - The company plans to use the raised funds for the "Anjisi Thailand Production Base Project" and has established a three-party supervision agreement for the management of the raised funds [3][4][43] Group 2 - The company will use its own foreign exchange funds to pay for part of the investment project during its implementation and will replace these with raised funds later, which is aimed at improving operational efficiency and reducing financial costs [5][6][7] - The company has approved the extension of the "Minimally Invasive Medical Device R&D Center Project" to December 31, 2026, due to the actual construction progress and strategic planning [4][54][55] - The supervisory board and the sponsor have confirmed that the use of foreign exchange funds and the extension of the investment project will not affect the normal implementation of the investment projects and will not harm the interests of shareholders [8][9][57] Group 3 - The company has established a detailed operational process for the use of its own foreign exchange funds and the subsequent replacement with raised funds, ensuring compliance with relevant regulations [6][8][9] - The company emphasizes the necessity and feasibility of the investment projects, highlighting the importance of technological innovation and talent attraction in maintaining competitive advantages in the medical device industry [46][50][51] - The company believes that the investment projects align with its strategic planning and will continue to monitor conditions for timely adjustments [52][53]

Group 1 - The board of directors of Luoyang Jianlong Micro-Nano New Materials Co., Ltd. held its 11th meeting of the 4th session on June 17, 2025, with all 8 directors present, ensuring compliance with legal and regulatory requirements [1] - The board decided not to lower the conversion price of "Jianlong Convertible Bonds" due to the long remaining term and recent market adjustments, affirming confidence in the company's future development [1][2] - The board approved a postponement of the "Adsorption Material Industrial Park Expansion Project (Phase II)" completion date from June 2025 to December 2026, without altering the project's implementation or funding [2] Group 2 - The board reviewed and approved amendments to certain internal management systems to align with the latest legal requirements, particularly following the cancellation of the supervisory board structure [2][3] - All resolutions passed unanimously with 8 votes in favor and no opposition or abstentions [2][3][4]

Core Viewpoint - The company, Guangdong Jushi Chemical Co., Ltd., is undergoing a delay in some of its fundraising projects, which has been reviewed and approved by its board of directors, ensuring compliance with relevant regulations and maintaining the integrity of its investment plans [1][5]. Fundraising Overview - The company raised a total of RMB 855.1667 million through the issuance of 23.333334 million shares at a price of RMB 36.65 per share, with all funds received by January 19, 2021 [1][2]. - The raised funds are stored in a special account approved by the board, with a regulatory agreement in place with the sponsoring institution and the bank [2]. Investment Project Status - As of March 31, 2025, the total planned investment for the projects is RMB 1.2005951 billion, with cumulative investment amounting to RMB 552.4919 million, achieving a progress rate of 99.39% [3]. - The company has decided to conclude certain projects and reallocate surplus funds to enhance liquidity [3]. Delay Details - The delay in the "Chizhou Halogen-Free Flame Retardant Expansion Project" and "Anqing Polystyrene Production Project" is attributed to various factors, including climate conditions, construction capabilities, equipment debugging, and administrative approvals [4]. - The company has taken a cautious approach to control the investment pace of the "Anqing Polystyrene Production Project" due to external economic conditions and internal strategic adjustments [4]. Measures for Completion - The company plans to closely monitor market changes, expedite administrative approvals, optimize resource allocation, and enhance project supervision to ensure timely completion of the delayed projects [4]. Impact of Delay - The delay is a prudent decision based on actual project conditions and does not alter the investment content, total investment, or intended use of funds, thus not significantly impacting the company's normal operations or shareholder interests [4][5]. - The company will continue to adhere to regulatory requirements and strengthen both internal and external oversight of fund usage [5].

Core Viewpoint - The company has decided to postpone the expected completion dates for two fundraising projects, which will not affect the overall investment content or total amount of the projects [1][4]. Fundraising Overview - The company raised a total of RMB 85,516.67 million from the public offering of 23,333,334 shares at a price of RMB 36.65 per share, with a net amount of RMB 77,572.97 million after deducting issuance costs [1][2]. - As of March 31, 2025, the total planned investment for the fundraising projects is RMB 120,059.51 million, with cumulative investment amounting to RMB 55,249.19 million, achieving a progress rate of 99.39% [2]. Project Delay Details - The postponement of the projects is due to various factors including climate conditions, construction capacity, equipment debugging, and administrative approvals affecting the "Chizhou Halogen-free Flame Retardant Expansion Project" [4]. - The "Anqing Polystyrene Production Project" faced delays due to macroeconomic conditions, market environment impacts, and internal adjustments in business focus and industry chain planning [4]. Measures for Completion - The company will closely monitor market changes, actively promote administrative approvals, optimize resource allocation, and enhance supervision of the fundraising projects to ensure timely completion [4]. Impact of Delay - The delay is a prudent decision based on actual project conditions and will not change the investment content or total amount of the projects, nor will it adversely affect the company's normal operations [4][5]. - The company will continue to comply with regulatory requirements and strengthen internal and external supervision of fundraising usage [4]. Approval Process - The board of directors approved the postponement of the fundraising projects, which does not require submission to the shareholders' meeting for further approval [5]. Sponsor's Opinion - The sponsor, Tianfeng Securities, confirmed that the postponement has been properly approved by the board and does not negatively impact the company's operations or shareholder interests [5].

Core Viewpoint - The company has decided to extend the timeline for the "Technology Reserve Fund Project" to December 2026, without changing the project’s implementation subject, method, or funding usage, ensuring no substantial impact on the project’s execution [1][3][4] Fundraising Overview - The company issued convertible bonds totaling RMB 380 million on June 28, 2023, with a net amount of RMB 371.09 million after deducting issuance costs [1][2] - The funds are allocated for projects including smart photovoltaic and battery management PLC chip R&D, and smart home multi-mode communication gateway and device PLC chip R&D [2] Project Delay Details - The original expected date for the "Technology Reserve Fund Project" to reach a usable state was June 2025, which has now been postponed to December 2026 [2][3] - The delay is based on the actual progress of the project and aims to align with the company's long-term development strategy [3] Impact of Delay - The delay is a prudent decision based on the project's actual situation and does not alter the investment direction or harm shareholder interests [3][4] - The project’s implementation will continue as planned, adhering to regulatory requirements and ensuring no adverse effects on the company or its shareholders [4] Approval Process - The board of directors approved the extension during a meeting on June 13, 2025, with no need for shareholder approval as confirmed by the sponsor, CITIC Securities [4]

Core Viewpoint - The company has decided to postpone the expected operational readiness date of its fundraising project "Bomin Electronics New Generation Electronic Information Industry Investment Expansion Project (Phase I)" from July 2025 to December 31, 2026, based on the actual construction progress and investment pace [4][6][7]. Fundraising Basic Situation - The company raised a total of RMB 150,000.00 million by issuing 12,701.10 million shares at a price of RMB 11.81 per share, with a net amount of RMB 147,348.60 million after deducting issuance costs [1][2]. Fundraising Investment Projects and Usage - The total investment amount for the project is RMB 248,172.66 million, with the adjusted amount for the "Bomin Electronics New Generation Electronic Information Industry Investment Expansion Project (Phase I)" set at RMB 112,348.60 million [2][3]. Postponement of Fundraising Projects - The postponement is due to the project's high degree of automation, complex production processes, and the need to align with market demand and resource allocation [5][6]. Measures to Ensure Completion After Postponement - The company will adhere to relevant regulations and strengthen supervision over the use of fundraising, ensuring legal and effective utilization of funds [5][6]. Impact of Postponement on the Company - The postponement will not materially affect the implementation of the fundraising project or the company's normal operations, aligning with the company's long-term development strategy [6][7]. Internal Review Procedures and Opinions - The board of directors and supervisory board have approved the postponement, confirming that it does not harm shareholder interests and complies with regulatory requirements [7][8].

证券代码：603936 证券简称：博敏电子 公告编号：临 2025-047 博敏电子股份有限公司 具体内容详见上海证券交易所网站（www.sse.com.cn）同日披露的公司《关 于部分募投项目延期的公告》（公告编号：临 2025-048）。 监事会认为：本次部分募投项目延期是根据市场环境的变化、投资进度等客 观情况作出的审慎决定，符合公司中长期发展战略，不存在损害股东特别是中小 股东利益的情形，履行了必要的审议程序，符合《上市公司监管指引第 2 号—— 上市公司募集资金管理和使用的监管要求》及公司《募集资金管理制度》的规定， 符合公司及全体股东的利益。监事会同意本次部分募投项目延期事项。 表决结果：3 票同意，0 票反对，0 票弃权。 特此公告。 博敏电子股份有限公司监事会 第五届监事会第十六次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 博敏电子股份有限公司（以下简称"公司"）第五届监事会第十六次会议于 会议室以现场表决方式召开。本次会议应到监事 3 人，实到监事 3 人，会议由监 事会主席曾铁城先生召集并 ...

Group 1 - The second meeting of the Supervisory Board of Zhongxin Ke Mobile Communication Technology Co., Ltd. was held on June 12, 2025, with all five supervisors present [1][2] - The Supervisory Board approved the proposal for the postponement of fundraising projects, stating that the adjustment was made based on the company's actual situation and did not harm the interests of the company or its shareholders [1][2] - The decision to postpone the fundraising projects complies with relevant laws and regulations from the China Securities Regulatory Commission and the Shanghai Stock Exchange [1]

Core Viewpoint - The company has decided to postpone the expected completion date of the "Shenzhen R&D Center Construction Project" from March 2026 to June 2027, while maintaining the project's investment purpose, scale, and implementation subject unchanged [5][6][7]. Fundraising and Investment Project Overview - The company issued 37,243,264 A-shares at a price of 19.30 RMB per share, raising a total of approximately 709.25 million RMB after deducting issuance costs [1][2]. - The funds are stored in a special account approved by the board, with a tripartite supervision agreement signed with the sponsor and the commercial bank [2]. Fund Usage and Investment Progress - As of March 31, 2025, the total investment amount for the projects is 919.41 million RMB, with 709.25 million RMB allocated, and 570.28 million RMB already invested, representing an investment progress of 80.41% [3][4]. Reasons for Project Delay - The delay is attributed to uncontrollable factors during the implementation phase, including issues with land approval, construction planning, and coordination with multiple parties, which have affected the construction progress [4][5]. Impact of Delay on the Company - The postponement does not change the investment purpose, location, or total investment amount of the projects, and is aimed at improving the efficiency of fund usage without harming shareholder interests [5][6]. Measures to Ensure Timely Completion - The company will closely monitor the progress of the investment projects and implement plans to ensure orderly advancement, while also considering macroeconomic and market changes [5][6]. Approval Procedures - The board of directors has approved the postponement of the project, confirming that all necessary procedures have been followed in compliance with relevant regulations [6][7].